PHARMALIS
Board
2 directors, last change in 2021Director (not named in the articles)
since 15-01-2021
term without a fixed end
earlier manager, until 25-01-2021
listed in the 2025 annual accounts, filed on 22-04-2026
Director (not named in the articles)
since 15-01-2021
term without a fixed end
earlier manager, until 25-01-2021
listed in the 2025 annual accounts, filed on 22-04-2026
Mandates through the years
2 names, the dashed line is todayDirector (not named in the articles)
Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
-
- Director (not named in the articles), from 15-01-2021 to date
- Manager, until 25-01-2021
-
- Director (not named in the articles), from 15-01-2021 to date
- Manager, until 25-01-2021
Control
Capital
- Contribution
- €27,047.16
- Shares
- 186
- Contribution per share
- €145
- Equity per share
- €459 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 25-01-2021 (in French)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
- Pour moitié à charge cédant et pour moitié à charge acquéreurs proportionnellement nombre actions acquises, déduction faite des actions dont cession proposée
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Last Friday of June at 20:00
Capital transactions
Capital over time
- 25-01-2021 Capital stated in the deed · 186 shares
- 10-12-2018 Capital reduction of €450,000 · to €18,600 · repaid to the shareholders
- 24-02-2014 Capital increase of €450,000 · to €468,600 · no new shares · in cash